Transgenic mice carrying immunoglobulin genes coding for it heavy chain and K light chain have been used to study the mechanisms involved in allelic and isotypic exclusion. We report here that individual cells from transgenic mice carrying a functionally rearranged la heavy chain gene (capable of generating both membrane and secreted forms of IgM) can rearrange an endogenous ,u heavy chain gene and simultaneously produce both transgenic and endogenous IgM. These "double-producing" cells express both endogenous and transgenic IgM in the cytoplasm (detected by immunohistology) and on the cell surface (detected by multiparameter fluorescence-activated cell sorter analysis). In addition, they secrete mixed IgM molecules containing both transgenic and endogenous 1L heavy chains (detected in serum by radioimmune assay). The transgenic mice studied also have relatively large numbers of cells that produce endogenous immunoglobulin in the absence of detectable transgenic immunoglobulin ("endogenous-only cells"). The mechanisms that generate double-producing cells and endogenous-only cells appear to be under genetic control because the frequencies of these B-cell populations are characteristic for a given transgenic line. Thus, our frndings indicate that more is involved in triggering allelic exclusion than the simple presence or absence of membrane ja heavy chains (as has been previously postulated).
Murine B cells generate by rearrangement a functional immunoglobulin heavy chain gene (Igh) on only one of the Igh-homologous chromosomes (1, 2) . This results in each B cell producing antibodies encoded by only one of two potential Igh-6 alleles encoding IgM (3, 4) , a phenomenon referred to as allelic (or haplotype) exclusion (4, 5) . The nature of the signals and/or mechanisms involved in allelic exclusion is not well understood; however, one commonly accepted view holds that the presence of the product of a functionally rearranged Igh gene prevents further rearrangement of the Igh-chromosomal region (1, 6) .
Recently, a series of studies has been published using transgenic mice carrying a functionally rearranged ,u heavy chain gene to test this hypothesis (6) (7) (8) (9) (10) (11) . Data from these studies have generally appeared consistent with the overall hypothesis; however, it is difficult to draw a firm conclusion from the evidence presented. Three potential problems cloud interpretation of these data: (i) in most of the previous studies, the expression of transgenic and endogenous IgM in individual B cells was primarily determined by analysis of cell lines (Abelson transformed lines or hybridomas) derived from the transgenic mice and are not necessarily representative of the B-cell populations actually present in the animals (7-11); (ii) several of the transgenic lines studied were made with outbred (F1) founder mice (6, (8) (9) (10) and, thus, will have considerable genetic variability, which may affect B-cell development; and (iii) our recent studies (with the M54 and M95 inbred transgenic mouse strains) demonstrate that the introduction of the immunoglobulin transgene can selectively block development of B-cell subpopulations (12) .
In studies presented here, we reopen the question of whether the presence of a functionally rearranged ,u heavy chain transgene ("g& Igh-Cb haplotype (13) . M54, M95, M94, and M52 transgenic lines were provided by R. Grosschedl (University of California, San Francisco). The development of these lines has been described in detail (14) . The transgenic ,234-4 mice were generously provided by U. Storb (University of Chicago) and R. Brinster (University of Pennsylvania) (9) .
Antibodies. The monoclonal mouse antibody AF6-78.25 is specific for IgM ofIgh-Cb haplotype strains of mice (15 optimal amounts of the anti-Igh-6a fluorescein isothiocyanate-conjugated DS-1 antibody and the anti-Igh-6b biotinconjugated antibody. Biotin-conjugated anti-Igh6b was revealed with Texas red-avidin. FACS analyses were conducted as described (17, 18) . Dead cells were stained with propidium iodide and excluded from the analyses (18) . For each analysis, data from 30,000 viable cells were collected. Data are presented as 5% probability contour maps (19 (9) , which has a different ,u transgene construct than the one in M54 and M95. Proc. Natl. Acad. Sci. USA 85 (1988) In contrast, FACS analyses of normal allotype heterozygotes, (BALB/c x SJL)F1 or (CB.17 x BALB/c)F1, revealed only the expected allelically excluded Igh-6a-only or Igh-6b-only B cells. Only background levels of cells that stain for both Igh-6a and -6b were detectable (<2% of B cells in peritoneum and <1% of B cells in spleen) (Fig. 1) Fig. 3 ). Thus, the hybridomas obtained were not representative ofthe distribution ofendog- (Figs. 1 and 3) . Similar differences were seen in the other lymphoid organs.
There was no apparent correlation of the frequency of Igh-6b-only and/or Igh-6a/6b cells in a given transgenic line with the number of copies of the transgene or the amount of transgene protein produced. The M52 and M95 lines, both of which had very high frequencies of-Igh-6b-only cells, had 140 and 17 copies, respectively, of the transgene (14), while M54, which had predominantly Igh-6a/6b cells, had 30 copies. All three lines produced similar levels of serum transgenic IgM (ref. 14; Table 2 ). The relative frequencies of Igh-6a-only, Igh-6b-only, and Igh-6a/6b B cells were reproducible and characteristic for each transgenic line. That is, M95 mice always showed high levels of Igh-6b-only cells, while M54 mice had high levels of double producers. The relative frequencies of each of the three cell types in another transgenic line, M52, were intermediate between those in M54 (Table 2) . These "mixed" IgM molecules were revealed in RIA assays in which anti-Igh-6a was used as the plate coat antibody and radiolabeled anti-Igh-6b was used as the revealing antibody (and vice versa). In these assays, radioac- 9 12 tivity is bound to the plate only if the serum contains (pentameric) IgM molecules that have endogenous and 11 37 transgenic tt heavy chains and, thus, can bind to both the anti-Igh-6a and anti-Igh-6b antibodies. 2 11 Although sera from all transgenic animals tested had substantial levels of mixed IgM molecules, no mixed mole- . These authors conclude that the Igh-S transgene markedly blocks endogenous Igh-6 rearrangement; however, approximately a third of the splenic B cells in these mice express endogenous Igh-6, and a significant fraction of these coexpress endogenous Igh-6 and the transgenic Igh-S. Hybridoma studies have also revealed the existence of cells expressing endogenous Igh genes in transgenic mice (8, 11) . Thus, although less attention has been paid to cells producing endogenous immunoglobulin in earlier studies of transgenic mice, rearrangement of the endogenous chromosome has not been completely suppressed in any Igh transgenic line studied.
Bringing the endogenous immunoglobulin production in IL transgenic mice into focus introduces a different perspective on studies of the mechanisms involved in allelic exclusion. The cells that express endogenous A heavy chain gene in the absence of detectable amounts of transgenic ,u heavy chain are perhaps the most intriguing in this respect. How does the expression of the functionally rearranged u transgene become blocked in these cells? It is unlikely that they have physically lost the transgene, since the frequency of endogenous-gene-only cells appears to be under strict genetic and developmental control (i.e., the frequencies are unique in each transgenic line and in each lymphoid tissue within a given line). Thus, the loss of transgene expression in these cells could reflect the existence of a second allelic exclusion mechanism that operates in these mice at the level of gene expression rather than rearrangement.
Finally, the frequent appearance of cells producing both transgenic and endogenous IgM in several transgenic lines shows that the production of membrane ,u heavy chain does not always result in allelic exclusion. This finding constitutes the severest challenge to the idea that the production of membrane ,u heavy chain is sufficient to block subsequent A heavy chain gene rearrangements in developing B cells. In essence, barring ad hoc hypotheses that allow for endogenous immunoglobulin gene rearrangement before sufficient levels of transgene membrane ,u heavy chain are expressed, the existence of double-producing cells suggests at a minimum that allelic exclusion is mediated by a more complex mechanism than previously postulated (6) .
